[Effect of fibrinogen degradation products on the functional state of the myometrium].
D001920:Bradykinin / Q000494:pharmacology; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism* / Q000494:pharmacology; D005341:Fibrinolysin / Q000378:metabolism; D006801:Humans; D007743:Labor, Obstetric; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D007744:Obstetric Labor Complications / Q000097:blood / Q000503:physiopathology; D010121:Oxytocin / Q000494:pharmacology; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000378:metabolism; D014599:Uterus / Q000187:drug effects / Q000502:physiology*
D010121:Oxytocin; D005337:Fibrin; D005340:Fibrinogen; D005341:Fibrinolysin; D001920:Bradykinin
Wpływ produktów degradacji fibrynogenu na stan czynnościowy myometrium.